Volume 11,Issue 1
Observation of the Effect of Irbesartan + Metoprolol in the Treatment of Hypertension and Analysis of its Impact on effectiveness
Objective: To analyze the clinical effectiveness of irbesartan combined with metoprolol in the treatment of hypertension and its impact on the effectiveness. Methods: 76 patients with hypertension admitted to our hospital from December 2023 to December 2024 were selected as the research subjects and divided into two groups using the random number table method. Thirty-eight patients in the experimental group were treated with irbesartan combined with metoprolol, and 38 patients in the conventional group were treated with irbesartan alone. The treatment effectiveness, incidence of adverse reactions, and blood pressure variability indicators before and after treatment were compared between the two groups. Results: The treatment effectiveness of the experimental group was higher than that of the conventional group (P < 0.05); the incidence of adverse reactions between the two groups was not significantly different (P > 0.05); the blood pressure variability index of the experimental group after intervention was better than that of the conventional group (P < 0.05). Conclusion: Irbesartan combined with metoprolol in the treatment of hypertension can improve the therapeutic efficiency, optimize blood pressure variability, and has good safety.
[1] Li HT, Qu LN, Zhang ZW, et al., 2025, Analysis of the Clinical Efficacy of Metoprolol Combined with Irbesartan in the Treatment of Hypertension Complicated with Heart Failure. Journal of Difficult Diseases, 24(6): 646–650.
[2] Yun JF, 2025, Analysis of the Clinical Efficacy of Amlodipine Besylate or Metoprolol Tartrate Combined with Irbesartan in the Treatment of Hypertension. Chinese Community Physicians, 41(14): 43–45.
[3] Mou YS, 2024, Effects of Metoprolol Combined with Irbesartan on Myocardial Damage Indicators and Adverse Reactions in Patients with Hypertension and Arrhythmia. Jilin Medicine, 45(12): 3072–3074.
[4] Zhang MY, 2024, Analysis of the Efficacy and Adverse Reactions of Metoprolol Combined with Irbesartan in the Treatment of Hypertension in the Elderly. Chinese Practical Medicine, 19(21): 96–99.
[5] Jin Y, Li Y, 2024, Discussion on the Clinical Effect of Metoprolol Combined with Irbesartan in the Treatment of Hypertension in the Elderly. Chinese Modern Drug Application, 18(9): 78–81.
[6] Xue GX, Liu H, Guo MF, 2023, Effect of Irbesartan Combined with Metoprolol Succinate in the Treatment of Young and Middle-Aged Patients with Hypertension. Chinese and Foreign Medical Research, 21(35): 1–4.
[7] Zhang L, Zhang L, 2022, Effect of Irbesartan Hydrochlorothiazide Combined with Metoprolol in Elderly Patients with Severe Heart Failure Caused by Hypertension. Chinese Contemporary Medicine, 29(34): 84–88.
[8] Shao YX, Sun ZW, Gan XY, et al., 2022, Effects of Combined Treatment with Irbesartan, Hydrochlorothiazide and Metoprolol on Blood Pressure Variability and Cardiorenal Function in Elderly Patients with Hypertension. Chinese Journal of Hospital Pharmacy, 42(24): 2650–2654.